Naturally Occurring A Pocket Polymorphism in HLA-B*2703 Increases the Dependence on an Accessory Anchor Residue at P1 for Optimal Binding of Nonamer Peptides

Journal of Immunology

Volumn 159, Issue 10, 1997, Pages 4887-4897

  Griffin, Thomas A ^a   Yuan, Jie ^b   Friede, Thomas ^c   Stevanovic, Stefan ^c   Ariyoshi, Koya ^d   Rowland Jones, Sarah L ^e   Rammensee, Hans Georg ^c   Colbert, Robert A ^a  

^a CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^b UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY OF TÜBINGEN   (Germany)

^d MEDICAL RESEARCH COUNCIL LABORATORIES   (Gambia)

^e UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; EPITOPE; HLA B ANTIGEN; OLIGOPEPTIDE; VIRUS ANTIGEN;

ALLELE; AMINO ACID SEQUENCE; ANTIGEN PRESENTATION; ARTICLE; CHEMICAL STRUCTURE; CHEMISTRY; COMPUTER SIMULATION; GENETIC POLYMORPHISM; GENETICS; HUMAN; IMMUNOLOGY; METABOLISM; PHYSIOLOGY; PROTEIN BINDING;

ALLELES; AMINO ACID SEQUENCE; ANTIGEN PRESENTATION; ANTIGENS, VIRAL; ARGININE; COMPUTER SIMULATION; EPITOPES; HLA-B ANTIGENS; HUMANS; MODELS, MOLECULAR; OLIGOPEPTIDES; POLYMORPHISM, GENETIC; PROTEIN BINDING;

EID: 0031573143     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (55)

1. Choo, S. Y., T. St. John, H. T. Orr, and J. A. Hansen. 1988. Molecular analysis of the variant alloantigen HLA-B27d (HLA-B*2703) identifies a unique single amino acid substitution. Hum. Immunol. 2:209.
2. Khan, M. A. 1995. HLA-B27 and its subtypes in world populations: editorial reviews. Curr. Opin. Rheumatol. 7:263.
3. Madden, D. R., J. C. Gorga, J. L. Strominger, and D. C. Wiley. 1992. The three-dimensional structure of HLA-B27 at 2.1 Å resolution suggests a general mechanism for tight peptide binding to MHC. Cell 70:1035.
4. Fremont, D. H., M. Matsumara, E. A. Stura, P. A. Peterson, and I. A. Wilson. 1992. Crystal structures of two viral peptides in complex with murine MHC class I H-2Kb. Science 257:919.
5. Matsumara, M., D. H. Fremont, P. A. Peterson, and I. A. Wilson. 1992. Emerging principles for the recognition of peptide antigens by MHC class I molecules. Science 257:927.
6. Madden, D. R., D. N. Garboczi, and D. C. Wiley. 1993. The antigenic identity of peptide-MHC complexes: a comparison of the conformations of five viral peptides presented by HLA-A2. Cell 75:693.
7. Young, A. C. M., W. Zhang, J. C. Sacchettini, and S. G. Nathenson. 1994. The three-dimensional structure of H-2Db at 2.4 Å resolution: implications for antigen-determinant selection. Cell 76:39.
8. Smith, K. J., S. W. Reid, D. I. Stuart, A. J. McMichael, E. Y. Jones, and J. I. Bell. 1996. An altered position of the α2 helix of MHC class I is revealed by the crystal structure of HLA-B*3501. Immunity 4:203.
9. Smith, K. J., S. W. Reid, K. Harlos, A. J. McMichael, D. I. Stuart, J. I. Bell, and E. Y. Jones. 1996. Bound water structure and polymorphic amino acids act together to allow the binding of different peptides to MHC class I HLA-B53. Immunity 4:215.
10. Latron, F., L. Pazmany, J. Morrison, R. Moots, M. A. Saper, A. McMichael, and J. L. Strominger. 1992. A critical role for conserved residues in the cleft of HLA-A2 in presentation of a nonapeptide to T cells. Science 257:964.
11. Colbert, R. A., S. L. Rowland-Jones, A. J. McMichael, and J. A. Frelinger. 1994. Differences in peptide presentation between B27 subtypes: the importance of the P1 side chain in maintaining high affinity peptide binding to B*2703. Immunity 1:121.
12. Bjorkman, P. J., and P. Parham. 1990. Structure, function, and diversity of class I major histocompatibility complex molecules. Annu. Rev. Biochem. 59:253.
13. Kikuchi, A., T. Sakaguchi, K. Miwa, Y. Takamiya, H.-G. Rammensee, Y. Kaneko, and M. Takiguchi. 1996. Binding of nonamer peptides to three HLA-B51 molecules which differ by a single amino acid substitution in the A-pocket. Immunogenetics 43:268.
14. Shawar, S. M., J. M. Vyas, J. R. Rodgers, and R. R. Rich. 1994. Antigen presentation by major histocompatibility complex class I-B molecules. Annu. Rev. Immunol. 12:839.
15. Wang, C.-R., A. R. Castano, P. A. Peterson, C. Slaughter, K. Fischer Lindahl, and J. Deisenhofer. 1995. Nonclassical binding of formylated peptide in crystal structure of the MHC class Ib molecule H2-M3. Cell 62:655.
16. Huet, S., D. F. Nixon, J. B. Rothbard, A. Townsend, S. A. Ellis, and A. J. McMichael. 1990. Structural homologies between two HLA B27-restricted peptides suggest residues important for interaction with HLA-B27. Int. Immunol. 2:311.
17. Jardetzky, T. S., W. S. Lane, R. A. Robinson, D. R. Madden, and D. C. Wiley. 1991. Identification of self peptides bound to purified HLA-B27. Nature 353:326.
18. Brooks, J. M., R. J. Murray, W. A. Thomas, M. G. Kurilla, and A. B. Rickinson. 1993. Different HLA-B27 subtypes present the same immunodominant Epstein-Barr virus peptide. J. Exp. Med. 178:879.
19. Buseyne, F., M. McChesney, F. Porrot, S. Kovarik, B. Guy, and Y. Riviere. 1993. Gag-specific cytotoxic T lymphocytes from human immunodeficiency virus type-1 infected individuals: Gag epitopes are clustered in three regions of the p24gag protein. J. Virol. 67:694.
20. Rotzschke, O., K. Falk, S. Stevanovic, V. Gnau, G. Jung, and H.-G. Rammensee. 1994. Dominant aromatic/aliphatic C-terminal anchor in HLA-B*2702 and B*2705 peptide motifs. Immunogenetics 39:74.
21. Villadangos, J. A., B. Galocha, D. Lopez, V. Calvo, and J. A. Lopez de Castro. 1992. Role of binding pockets for amino terminal peptide residues in HLA-B27 allorecognition. J. Immunol. 149:505.
22. Lopez, D., R. Garcia-Hoyo, and J. A. Lopez de Castro. 1994. Clonal analysis of alloreactive T cell responses against the closely related B*2705 and B*2703 subtypes. J. Immunol. 152:5557.
23. Villadangos, J. A., B. Galocha, R. Garcia-Hoyo, D. Lopez, H. Garcia, and J. A. Lopez de Castro. 1994. Structure of HLA-B27-specific T cell epitopes. Antigen presentation in B*2703 is limited to a subset of the antigenic determinants on B*2705. Eur. J. Immunol. 24:2548.
24. Storkus, W. J., D. N. Howell, R. D. Salter, J. R. Dawson, and P. Cresswell. 1987. NK susceptibility varies inversely with target cell class I HLA antigen expression. J. Immunol. 138:1657.
25. Salter, R. D., D. M. Howell, and P. Cresswell. 1985. Genes regulating HLA class I antigen expression in T-B lymphoblast hybrids. Immunogenetics 21:235.
26. Barnstable, C. J., W. J. Bodmer, G. Brown, G. Galfre, C. Milstein, A. F. Williams, and A. Zeigler. 1978. Production of monoclonal antibodies to group A erythrocytes, HLA and other human cell surface antigens - new tools for genetic analysis. Cell 14:9.
27. Falk, K., O. Rotzschke, S. Stevanovic, G. Jung, and H.-G. Rammensee. 1991. Allele-specific motifs revealed by sequencing self peptides eluted from MHC molecules. Nature 351:290.
28. Elvin, J., C. Potter, T. Elliott, V. Cerundolo, and A. Townsend. 1993. A method to quantitate binding of unlabeled peptides to class I MHC molecules and detect their allele specificity. J. Immunol. Methods 158:161.
29. Parker, K. C., W. E. Biddison, and J. E. Coligan. 1994. Pocket mutations of HLA-B27 show that anchor residues act cumulatively to stabilize peptide binding. Biochemistry 33:7736.
30. Elvin, J., V. Cerundolo, T. Elliott, and A. Townsend. 1991. A quantitative assay of peptide-dependent class I assembly. Eur. J. Immunol. 21:2025.
31. Cerundolo, V., T. Elliott, J. Elvin, J. Bastin, H.-G. Rammensee, and A. Townsend. 1991. The binding affinity and dissociation rates of peptides for class I major histocompatibility complex molecules. Eur. J. Immunol. 21:2069.
32. Goulder, P. J. R., R. E. Phillips, R. A. Colbert, S. McAdam, G. Ogg, M. Nowak, P. Giangrande, G. Luzzi, B. Morgan, A. Edwards, A. J. McMichael, and S. Rowland-Jones. 1997. Late escape from an immunodominant cytotoxic T-lymphocyte response associated with progression to AIDS. Nat. Med. 3:212.
33. Bunce, M., C. M. O'Neill, M. C. Barnardo, P. Krausa, M. J. Browning, P. J. Morris, and K. I. Welsh. 1995. Phenotyping: comprehensive DNA typing for HLA-A, B, C, DRB1, DRB3, DRB4, DRB5, & DQB1 by PCR with 144 primer mixes utilizing sequence-specific primers. Tissue Antigens 46:355.
34. Nixon, D. F., A. R. M. Townsend, J. G. Elvin, C. R. Rizza, J. Gallwey, and A. J. McMichael. 1988. HIV-1 gag-speciftc cytotoxic T lymphocytes defined with recombinant vaccinia virus and synthetic peptides. Nature 336:484.
35. Rowland-Jones, S. L., J. Sutton, K. Ariyoshi, T. Dong, F. M. Gotch, S. McAdam, D. Whitby, S. Sabally, A. Gallimore, T. Corrah, M. Takiguchi, T. Schultz, A. J. McMichael, and H. Whittle. 1995. HIV-specific cytotoxic T cells in HIV-exposed but uninfected Gambian women. Nat. Med. 1:59.
36. Rowland-Jones, S. L., S. H. Powis, J. Sutton, I. Mockridge, F. M. Gotch, N. Murray, A. B. Hill, W. M. Rosenberg, J. Trowsdale, and A. J. McMichael. 1993. An antigen processing polymorphism revealed by HLA-B8-restricted cytotoxic T lymphocytes which does not correlate with TAP gene polymorphism. Eur. J. Immunol. 23:1999.
37. Rammensee, H.-G., K. Falk, and O. Rotzschke. 1993. Peptides naturally presented by MHC class I molecules. Annu. Rev. Immunol. 11:213.
38. Ruppert, J., J. Sidney, E. Celis, R. T. Kubo, H. M. Grey, and A. Sette. 1993. Prominent role of secondary anchor residues in peptide binding to HLA-A2.1 molecules. Cell 74:929.
39. Engelhard, V. H. 1994. Structure of peptides associated with class I and class II MHC molecules. Annu. Rev. Immunol. 12:181.
40. Sette, A., J. Sidney, M.-F. del Guercio, S. Southwood, J. Ruppert, C. Dahlberg, H. M. Grey, and R. T. Kubo. 1994. Peptide binding to the most frequent HLA-A class I alleles measured by quantitative molecular binding assays. Mol. Immunol. 31:813.
41. Hill, A. V. S., C. E. M. Allsop, D. Kwiatkowski, N. M. Antsey, B. M. Greenwood, and A. J. McMichael. 1991. HLA class I typing by PCR: HLA-B27 and an African B27 subtype. Lancet 337:640.
42. Kondo, A., J. Sidney, S. Southwood, M.-F. del Guercio, E. Appella, H. Sakamato, E. Celis, H. M. Grey, R. W. Chesnut, R. T. Kubo, and A. Sette. 1995. Prominent roles of secondary anchor residues in peptide binding to HLA-A24 human class I molecules. J. Immunol. 155:4307.
43. Rogue, R. R., J. Eron, J. A. Frelinger, and M. Matsui. 1995. Amino-terminal alteration of the HLA-A*0201-restricted human immunodeficiency virus pol peptide increase complex stability and in vitro immunogenicity. Proc. Natl. Acad. Sci. USA 92:8166.
44. Fukazawa, T., J. Wang, F. Huang, J. Wen, D. Tyan, K. M. Williams, R. B. Raybourne, and D. T. Y. Yu. 1994. Testing the importance of each residue in a HLA-B27-binding peptide using monoclonal antibodies. J. Immunol. 152: 1190.
45. Wen, J., J. Wang, J. G. Kuipers, F. Huang, K. M. Williams, R. B. Raybourne, and D. T. Y. Yu. 1994. Analysis of HLA-B*2705 peptide motif, using T2 cells and monoclonal antibody ME1. Immunogenetics 39:444.
46. Parker, K., M. A. Bednarek, and J. E. Coligan. 1994. Scheme for ranking potential HLA-A2 binding peptides based on independent binding of individual side-chains. J. Immunol. 152:163.
47. Boisgerault, F., V. Tieng, M.-C. Stolzenberg, N. Dulphy, I. Khalil, R. Tamouza, D. Charron, and A. Toubert. 1996. Differences in endogenous peptides presented by HLA-B*2705 and B*2703 allelic variants. J. Clin. Invest. 989:2764.
48. Tanigaki, N., D. Fruci, E. Vigneti, G. Starace, P. Rovero, M. Londei, R. H. Butler, and R. Tosi. 1994. The peptide binding specificity of HLA-B27 subtypes. Immunogenetics 40:192.
49. Villadangos, J. A., B. Galocha, F. Garcia, J. P. Albar, and J. A. Lopez de Castro. 1995. Modulation of peptide binding by HLA-B27 polymorphism in pockets A and B, and peptide specificity of B*2703. Eur. J. Immunol. 25:2370.
50. 2-microglobulin. Proc. Natl. Acad. Sci. USA 89:7767.
51. Huczko, E. L., W. M. Bodnar, D. Benjamin, K. Sakaguchi, N. Z. Zhu, J. Shabanowitz, R. A. Henderson, E. Appella, D. F. Hunt, and V. H. Engelhard. 1993. Characteristics of endogenous peptides eluted from the class I MHC molecule HLA-B7 determined by mass spectrometry and computer modeling. J. Immunol. 151:2572.
52. Urban, R. G., R. M. Chicz, W. S. Lane, J. L. Strominger, A. Rehm, M. J. H. Kenter, F. G. C. M. Uytde-Haag, H. Ploegh, B. Uchanska-Ziegler, and A. Ziegler. 1994. A subset of HLA-B27 molecules contains peptides much longer that nonamers. Proc. Natl. Acad. Sci. USA 91:1534.
53. Lopez-Larrea, C., K. Sujirachato, N. K. Mehra, P. Chiewsilp, D. Isarangkura, U. Kanga, O. Dominguez, E. Coto, M. Pena, F. Setien, and S. Gonzalez-Roces. 1995. HLA-B27 subtypes in Asian patients with ankylosing spondylitis: evidence for new associations. Tissue Antigens 45:169.
54. Brown, M. A., A. Jepson, A. Young, H. C. Whittle, B. M. Greenwood, and B. P. Wordsworth. 1997. Ankylosing spondylitis in West Africans: evidence for a non-HLA-B27 protective effect. Ann. Rheum. Dis. 56:68.
55. Phillips, R. E., S. L. Rowland-Jones, D. F. Nixon, F. M. Gotch, J. P. Edwards, A. O. Ogunlesi, J. G. Elvin, J. A. Rothbard, C. R. Rizza, C. R. M. Bangham, and A. J. McMichael. 1991. HIV genetic variation that can escape cytotoxic T cell recognition. Nature 354:453.